- 現金殖利率: 3.56%、總殖利率: 3.56%、5年平均現金配發率: 110.76%
- 要留意資產負債表的未分配盈餘和配息能力, 如果為負值, 可能會無法發放股利
- 股利有2個稅要支出, 分別是綜合所得稅和健保補充保費(單筆股利達2萬元以上, 課2.11%)
| EPS YoY | 現金股利 YoY | 股票股利 YoY | 現金配發率 YoY | 股票配發率 YoY | 全部配發率 YoY | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023 (10) | 0.53 | -77.82 | 1.00 | -33.33 | 0.00 | 0 | 188.68 | 200.63 | 0.00 | 0 | 188.68 | 200.63 |
| 2022 (9) | 2.39 | 115.32 | 1.50 | 94.81 | 0.00 | 0 | 62.76 | -9.53 | 0.00 | 0 | 62.76 | -9.53 |
| 2021 (8) | 1.11 | -85.16 | 0.77 | -61.5 | 0.00 | 0 | 69.37 | 159.44 | 0.00 | 0 | 69.37 | 159.44 |
| 2020 (7) | 7.48 | 1458.33 | 2.00 | 102.02 | 0.00 | 0 | 26.74 | -87.04 | 0.00 | 0 | 26.74 | -87.04 |
| 2019 (6) | 0.48 | -76.7 | 0.99 | 12.5 | 0.00 | 0 | 206.25 | 382.81 | 0.00 | 0 | 206.25 | 60.94 |
| 2018 (5) | 2.06 | 524.24 | 0.88 | 76.0 | 1.76 | 0 | 42.72 | -71.81 | 85.44 | 0 | 128.16 | -15.42 |
| 2017 (4) | 0.33 | -68.87 | 0.50 | -50.98 | 0.00 | 0 | 151.52 | 57.46 | 0.00 | 0 | 151.52 | 57.46 |
| 2016 (3) | 1.06 | -54.31 | 1.02 | 2.0 | 0.00 | 0 | 96.23 | 123.25 | 0.00 | 0 | 96.23 | 123.25 |
| EPS QoQ YoY | 本業EPS QoQ YoY | 累計EPS QoQ YoY | |||||||
|---|---|---|---|---|---|---|---|---|---|
| 24Q3 (20) | -0.12 | -122.22 | -114.12 | 0.13 | -74.0 | -79.03 | 0.02 | -85.71 | -60.0 |
| 24Q2 (19) | 0.54 | 235.0 | 162.07 | 0.50 | 157.47 | 144.25 | 0.14 | 135.0 | 117.28 |
| 24Q1 (18) | -0.40 | -183.33 | -766.67 | -0.87 | -220.83 | -970.0 | -0.40 | -175.47 | -766.67 |
| 23Q4 (17) | 0.48 | -43.53 | 900.0 | 0.72 | 16.13 | 118.18 | 0.53 | 960.0 | -78.88 |
| 23Q3 (16) | 0.85 | 197.7 | 14.86 | 0.62 | 154.87 | 376.92 | 0.05 | 106.17 | -98.12 |
| 23Q2 (15) | -0.87 | -1550.0 | -197.75 | -1.13 | -1230.0 | -340.43 | -0.81 | -1450.0 | -141.54 |
| 23Q1 (14) | 0.06 | 200.0 | -94.39 | 0.10 | -69.7 | -85.07 | 0.06 | -97.61 | -94.39 |
| 22Q4 (13) | -0.06 | -108.11 | -220.0 | 0.33 | 153.85 | 320.0 | 2.51 | -5.64 | 107.44 |
| 22Q3 (12) | 0.74 | -16.85 | 428.57 | 0.13 | -72.34 | 333.33 | 2.66 | 36.41 | 127.35 |
| 22Q2 (11) | 0.89 | -16.82 | -3.26 | 0.47 | -29.85 | -34.72 | 1.95 | 82.24 | 89.32 |
| 22Q1 (10) | 1.07 | 2040.0 | 872.73 | 0.67 | 546.67 | 857.14 | 1.07 | -11.57 | 872.73 |
| 21Q4 (9) | 0.05 | -64.29 | 106.67 | -0.15 | -600.0 | 64.29 | 1.21 | 3.42 | -84.53 |
| 21Q3 (8) | 0.14 | -84.78 | -89.15 | 0.03 | -95.83 | -97.39 | 1.17 | 13.59 | -86.4 |
| 21Q2 (7) | 0.92 | 736.36 | -86.69 | 0.72 | 928.57 | 16.13 | 1.03 | 836.36 | -85.93 |
| 21Q1 (6) | 0.11 | 114.67 | -73.17 | 0.07 | 116.67 | -74.07 | 0.11 | -98.59 | -73.17 |
| 20Q4 (5) | -0.75 | -158.14 | -20.97 | -0.42 | -136.52 | -31.25 | 7.82 | -9.07 | 1464.0 |
| 20Q3 (4) | 1.29 | -81.33 | 0.0 | 1.15 | 85.48 | 0.0 | 8.60 | 17.49 | 0.0 |
| 20Q2 (3) | 6.91 | 1585.37 | 0.0 | 0.62 | 129.63 | 0.0 | 7.32 | 1685.37 | 0.0 |
| 20Q1 (2) | 0.41 | 166.13 | 0.0 | 0.27 | 184.38 | 0.0 | 0.41 | -18.0 | 0.0 |
| 19Q4 (1) | -0.62 | 0.0 | 0.0 | -0.32 | 0.0 | 0.0 | 0.50 | 0.0 | 0.0 |
| 年/月 | 營收 | 月增率(%) | 去年同期年增率(%) | 累計營收 | 累計營收年增率(%) | 近三月累計營收 | 存貨銷售比 | 自結稅前EPS | 自結稅前累計EPS | 備註(年增率變動50%需說明原因) |
|---|---|---|---|---|---|---|---|---|---|---|
| 2024/10 | 2.71 | -6.38 | 34.25 | 24.8 | 11.56 | 9.22 | N/A | - | ||
| 2024/9 | 2.89 | -20.1 | 27.73 | 22.09 | 9.3 | 8.42 | 0.99 | - | ||
| 2024/8 | 3.62 | 89.79 | -0.36 | 19.2 | 6.97 | 8.23 | 1.01 | - | ||
| 2024/7 | 1.91 | -29.45 | 15.7 | 15.58 | 8.83 | 7.42 | 1.12 | - | ||
| 2024/6 | 2.7 | -3.83 | 49.5 | 13.67 | 7.94 | 7.54 | 0.98 | - | ||
| 2024/5 | 2.81 | 38.7 | 47.19 | 10.97 | 1.02 | 7.45 | 0.99 | - | ||
| 2024/4 | 2.03 | -22.51 | 12.17 | 8.16 | -8.82 | 6.24 | 1.19 | - | ||
| 2024/3 | 2.62 | 63.35 | -10.23 | 6.13 | -14.13 | 6.13 | 1.03 | - | ||
| 2024/2 | 1.6 | -16.46 | -27.57 | 3.52 | -16.82 | 7.71 | 0.82 | - | ||
| 2024/1 | 1.92 | -54.31 | -5.04 | 1.92 | -5.04 | 9.53 | 0.67 | - | ||
| 2023/12 | 4.2 | 22.87 | 56.05 | 29.84 | -7.27 | 9.63 | 0.59 | 主要為子公司承攬之國軍302案，於本期出貨增加 | ||
| 2023/11 | 3.41 | 69.34 | 55.24 | 25.64 | -13.05 | 7.69 | 0.74 | 主要為子公司承攬之國軍302案，於本期出貨增加 | ||
| 2023/10 | 2.02 | -10.93 | -2.89 | 22.23 | -18.55 | 7.91 | 0.72 | - | ||
| 2023/9 | 2.26 | -37.67 | -17.72 | 20.21 | -19.84 | 7.54 | 0.91 | - | ||
| 2023/8 | 3.63 | 120.39 | 46.33 | 17.95 | -20.1 | 7.09 | 0.97 | - | ||
| 2023/7 | 1.65 | -8.83 | -34.98 | 14.31 | -28.35 | 5.37 | 1.29 | - | ||
| 2023/6 | 1.81 | -5.31 | -23.33 | 12.67 | -27.39 | 5.52 | 1.1 | - | ||
| 2023/5 | 1.91 | 5.7 | -35.31 | 10.86 | -28.02 | 6.63 | 0.91 | - | ||
| 2023/4 | 1.81 | -37.99 | -40.64 | 8.95 | -26.25 | 6.93 | 0.87 | - | ||
| 2023/3 | 2.91 | 31.8 | -25.12 | 7.14 | -21.43 | 7.14 | 0.84 | - | ||
| 2023/2 | 2.21 | 9.51 | 6.55 | 4.23 | -18.68 | 6.92 | 0.87 | - | ||
| 2023/1 | 2.02 | -24.92 | -35.42 | 2.02 | -35.42 | 6.91 | 0.87 | - | ||
| 2022/12 | 2.69 | 22.23 | -3.16 | 32.18 | 11.74 | 6.96 | 0.96 | - | ||
| 2022/11 | 2.2 | 5.92 | -3.8 | 29.49 | 13.33 | 7.03 | 0.95 | - | ||
| 2022/10 | 2.08 | -24.54 | -16.8 | 27.29 | 14.98 | 7.31 | 0.91 | - | ||
| 2022/9 | 2.75 | 10.85 | 32.66 | 25.21 | 18.71 | 7.77 | 0.85 | - | ||
| 2022/8 | 2.48 | -2.09 | 9.21 | 22.46 | 17.2 | 7.38 | 0.9 | - | ||
| 2022/7 | 2.54 | 7.5 | -3.43 | 19.98 | 18.28 | 7.85 | 0.85 | - | ||
| 2022/6 | 2.36 | -20.11 | -24.57 | 17.45 | 22.28 | 8.35 | 0.78 | - | ||
| 2022/5 | 2.95 | -3.0 | -11.19 | 15.09 | 35.43 | 9.89 | 0.66 | - | ||
| 2022/4 | 3.04 | -21.77 | 18.34 | 12.13 | 55.26 | 9.01 | 0.73 | 去年同期受疫情影響，今年營收因市場需求較去年同期成長。 | ||
| 2022/3 | 3.89 | 87.55 | 49.56 | 9.09 | 73.37 | 9.09 | 0.77 | 去年同期受疫情影響，今年營收因市場需求較去年同期成長。 | ||
| 2022/2 | 2.07 | -33.63 | 60.67 | 5.2 | 96.82 | 7.98 | 0.88 | 去年同期受疫情影響，今年營收因市場需求較去年同期成長。 | ||
| 2022/1 | 3.13 | 12.58 | 131.36 | 3.13 | 131.36 | 8.19 | 0.85 | 去年同期受疫情影響，今年營收因市場需求較去年同期成長。 | ||
| 2021/12 | 2.78 | 21.43 | 51.59 | 28.8 | 36.81 | 7.56 | 0.99 | 去年同期受疫情影響，今年營收因市場需求較去年同期成長。 | ||
| 2021/11 | 2.29 | -8.39 | 81.11 | 26.02 | 35.4 | 6.86 | 1.09 | 去年同期受疫情影響，今年營收因市場需求較去年同期成長。 | ||
| 2021/10 | 2.5 | 20.33 | 68.86 | 23.73 | 32.19 | 6.84 | 1.1 | 去年同期受疫情影響，今年營收因市場需求較去年同期成長。 | ||
| 2021/9 | 2.07 | -8.74 | -11.22 | 21.24 | 28.9 | 6.97 | 1.02 | - | ||
| 2021/8 | 2.27 | -13.43 | -6.93 | 19.16 | 35.53 | 8.03 | 0.88 | - | ||
| 2021/7 | 2.63 | -16.02 | 70.43 | 16.89 | 44.4 | 9.08 | 0.78 | 去年同期受疫情影響，今年營收因市場需求較去年同期成長。 | ||
| 2021/6 | 3.13 | -5.94 | 19.31 | 14.27 | 40.45 | 9.02 | 0.7 | - | ||
| 2021/5 | 3.32 | 29.26 | 98.06 | 11.14 | 47.8 | 8.5 | 0.74 | 去年同期受疫情影響，今年營收因市場需求較去年同期成長。 | ||
| 2021/4 | 2.57 | -1.13 | 56.93 | 7.82 | 33.4 | 6.46 | 0.97 | 無 | ||
| 2021/3 | 2.6 | 101.49 | 51.3 | 5.24 | 24.26 | 5.24 | 1.19 | 無 | ||
| 2021/2 | 1.29 | -4.43 | -2.98 | 2.64 | 5.67 | 4.47 | 1.4 | 無 | ||
| 2021/1 | 1.35 | -26.23 | 15.53 | 1.35 | 15.53 | 4.44 | 1.41 | 無 | ||
| 2020/12 | 1.83 | 45.08 | 91.93 | 21.05 | 33.21 | 4.57 | 1.13 | 無 | ||
| 2020/11 | 1.26 | -14.59 | 40.56 | 19.22 | 29.44 | 5.08 | 1.02 | 無 | ||
| 2020/10 | 1.48 | -36.74 | -2.22 | 17.95 | 28.72 | 6.26 | 0.83 | 無 | ||
| 2020/9 | 2.34 | -4.33 | 70.01 | 16.48 | 32.48 | 6.32 | 0.81 | 無 | ||
| 2020/8 | 2.44 | 58.53 | 74.02 | 14.14 | 27.82 | 6.6 | 0.78 | 無 | ||
| 2020/7 | 1.54 | -41.21 | 26.01 | 11.7 | 21.11 | 5.84 | 0.88 | - | ||
| 2020/6 | 2.62 | 56.12 | 123.76 | 10.16 | 20.4 | 5.94 | 0.95 | 受新冠肺炎疫情影響，醫療防護產品銷售增加 | ||
| 2020/5 | 1.68 | 2.42 | -10.08 | 7.54 | 3.74 | 5.04 | 1.12 | 無 | ||
| 2020/4 | 1.64 | -4.68 | 4.93 | 5.86 | 8.52 | 4.69 | 1.21 | - | ||
| 2020/3 | 1.72 | 29.19 | 33.58 | 4.22 | 9.98 | 4.22 | 0.83 | - | ||
| 2020/2 | 1.33 | 13.8 | 43.35 | 2.5 | -1.93 | 3.45 | 1.02 | - | ||
| 2020/1 | 1.17 | 22.55 | -27.86 | 1.17 | -27.86 | 3.02 | 1.16 | - | ||
| 2019/12 | 0.95 | 6.25 | -26.55 | 15.8 | -1.49 | 0.0 | N/A | - | ||
| 2019/11 | 0.9 | -40.59 | -41.93 | 14.85 | 0.71 | 0.0 | N/A | - |
